Keywords
Abstract
Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia that complicates the course of various cardiovascular diseases, and is also
accompanied by the frequent development of thromboembolic complications (TEC), primarily ischemic stroke. Purpose study is to obtain data on the prevalence of various forms of AF and compliance of the prevention of TEC on the use of anticoagulant agents on the territory of individual family polyclinics (FP) of Syrdarya region (Uzbekistan). Methods: To achieve this goal, FP№3 of the city of Gulistan and FP№14 of the Gulistan district of the Syrdarya region were randomly selected (urban and rural). With the help of electronic mathematical program were allocated by random selection method for FP№3 -1064 persons, and for FP№14 -812 persons. Results: in FP№3 in the age group of 40-49years, AF was detected in 1.11%, in the group of 50-59years, AF was detected in 0.56%, in the age category of 60 69years - in 2.27% of those examined. It should be noted that the detection of AF increased with age, reaching a maximum in the category of 90-91years (50%). In the age group over 80years, the prevalence of AF was 12.5%. And when analyzing rural areas (FP№14) in the age group of 50-59 years, AF was detected in 1.31%, and in the group of 60-69years 1.47%. At the outpatient stage, insufficient adequacy of the prevention of TEC was revealed in patients with AF studied both in urban (27%) and rural (25%) clinic.Conclusion: The prevalence of AF among the adult population of individual clinics in the city of Gulistan (1.03%) is 2 times higher than among the population of a rural clinic (0.49%). At the outpatient stage insufficient adequacy was revealed both
in individual urban and rural AF. Thus, more than 70% of patients with AF have a high risk of death and disability.
References
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal (2016) 37, 2893–2962. doi:10.1093/eurheartj/ehw210
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European doi:10.1093/eurheartj/ehaa612 Heart Journal
(2020) 00, 1-126.
Mareev Yu.V., Polyakov D.S., Vinogradova N.G., Fomin I.V., Mareev V.Yu., Belenkov Yu.N., Ageev F.T., Artemjeva E.G., Badin Yu.V., Bakulina E.V., Galyavich A.S., Ionova T.S., Kamalov G.M., Kechedzhieva S.G., Koziolova N.A., Malenkova V.Yu., Malchikova S.V., Smirnova E.A., Tarlovskaya E.I., Shcherbinina E.V., Yakushin S.S. Epidemiology of atrial fibrillation in a representative sample of the European part of the Russian Federation. Analysis of EPOCH-CHF study. Kardiologiia.
;62(4):12-19. Russ.) https://doi.org/10.18087/cardio.2022.4.n1997 (In
Марданов Б.У., Корнеева М.Н., Ахмедова Э.Б. Анализ последних международных клинических исследований по фибрилляции предсердий: тенденции и перспективы // Международный журнал сердца и сосудистых
заболеваний. ― 2015. ― Т.3 ―№8 ― С. 11–17. [Mardanov BU, Korneeva MN, Ahmedova ЕB. Analysis of latest international guidelines for atrial fibrillation: trends and perspectives. Mezhdunarodnyi zhurnal serdca i sosudistyh zabolevanii. 2015;3(8):11–17. (In Russ).]
Gilyarov M.Yu., Konstantinova E.V. Atrial fibrillation as a risk factor for ischemic stroke. Consilium Medicum. 2015; 17 (9): 16–19.
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the doi:10.1161/01.STR.22.8.983 Framingham Study. Stroke. 1991;22:982-8.
Е. И. Баранова. Новые стандарты безопасности антикоагулянтной терапии при фибрилляции предсердий Российский кардиологический журнал. 2018;23(10):136–144. http://dx.doi.org/10.15829/1560-4071-2018-10-136-144
Кропачева Е.С., Землянская О.А., Добровольский А.Б., Панченко Е.П. Эффективность длительной терапии варфарином: влияние на частоту ишемических нарушений мозгового кровообращения и клинические
предикторы их развития (результаты проспективного 10-летнего наблюдения) // Атеротромбоз. ― 2017. ― №2 ― С. 115–130. [Kropacheva ES, Zemljanskaja OA, Dobrovol’skii AB, Panchenko EP. The efficacy of long-term warfarin therapy: the impact on the incidence of ischemic cerebrovascular disorders and clinical predictors of developing such disorders. (Results of a prospective 10-year follow-up study). Atherothrombosis J. 2017;(2):115–130. (In Russ).] doi: 10.21518/2307-1109-2017-2115-130.
The Lancet Neurology. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease 28 European Journal of Research volume 9 issue 2 2024 pages 17-30
Study 2019.
World Stroke Organization. Fact Sheet. https://www.worldstroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf
Kakkar AK, Mueller I, Bassand JP, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). AHJ. 2012;163(1):13–19. doi:
1016/j.ahj.2011.09.011.
Skirdenko YuP, Nikolaev NA, Livzan MA, Ershov AV. Anticoagulant Therapy for Atrial Fibrillation in Real Practice: Problems and Prospects. Annals of the Russian Academy of Medical Sciences. 2019;74(2):98–107. doi: 10.15690/vramn1116)
Диагностика и лечение фибрилляции предсердий. Клинические рекомендации [интернет]. / Под ред. акад. А.Ш. Ревишвили. — Всероссийское научное общество специалистов по клинической электрофизиологии,
аритмологии и электрокардиостимуляции (ВНОА) в сотрудничестве с Российским кардиологическим обществом (РКО) и Ассоциацией сердечнососудистых хирургов России (АССХ); 2018. [Diagnostika i lechenie fibrillyatsii
predserdii. Klinicheskie rekomendatsii [Internet]. Ed by Revishvili ASh. Vserossiiskoe Nauchnoe Obshhestvo specialistov po klinicheskoi jelektrofiziologii, Aritmologii I jelektrokardiostimuljacii (VNOA) v sotrudnichestve s Rossiiskim
Kardiologicheskim obshhestvom (RKO) i Associacii serdechnososudistyh hirurgov Rossii (ASSH); 2018. (In Russ).]
http://scardio.ru/rekomendacii/rekomendacii_rko_close/.
Доступно по:Каримов Ш.И., Юлбарисов А.А., Суннатов Р.Д. Диагностика и лечение больных с хронической сосудисто-мозговой недостаточностью ишемического генеза. Методическое пособие. Ташкент 2018г.
Каримов Ш.И., Юлбарисов А.А., Суннатов Р.Д. Диагностика и лечение больных с хронической сосудисто-мозговой недостаточностью ишемического генеза при сочетанном поражении коронарного русла. Методическое пособие. Ташкент 2018г.
Абсолютная точность и другие иллюзии. Секреты статистики. Пере Грима. ISBN: 978-5-9774-0682-6, 978-5-9774-0706-9 (т. 13) Год издания: 2014. https://www. livelib.ru/ book/1000943720-absolyutnaya-tochnost-i-drugie-illyuzii sekrety-statistiki-pere-grima
Мангейм Дж.Б., Рич Р.К. Политология: Методы исследования. – М., 1997. С.517.
Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010 Jun;123(6):484-8. Review. PubMed ID: 20569748
Lip GY. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med. 2011 Feb;124(2):1114. PubMed ID: 20887966 29 European Journal of Research volume 9 issue 2 2024 pages 17-30
Ревишвили А.Ш., Сулимов В.А. Фибрилляция и трепетание предсердий (практическое руководство) // Кардиология: Новости. Мнения. Обучение. 2022. №4 (31).
Курбанов Р.Д., Закиров Н.У., Ирисов Дж.Б., Ганиев Т.З., Режаббоев Х.А. Адекватность антитромботической терапии у больных с фибрилляцией предсердий в реальной клинической практике. Бюллетень Ассоциации Врачей Узбекистана. №1, 2017г. Стр 10-14.